Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2016-12-28FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine from Dr. Reddy's Laboratories Limited, indicating a labeling-related update to the ge…
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for fluoxetine hydrochloride from Lannett Company, Inc., resulting in approval of their generic fluo…
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride from PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA granted a supplemental approval for a generic fluoxetine product from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
The FDA approved a supplemental application for fluoxetine (generic) from Saptalis Pharmaceuticals, LLC, for continued marketing under the a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-12-23FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride (generic) manufactured by Mylan Pharmaceuticals Inc.; this represen…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Mental Health Services for Foster and Adopted Children [Phase 1]
Phase 1 clinical trial evaluating mental health services for foster and adopted children has completed. It addresses attention-deficit/hyper…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused Intervention [NA]
This clinical trial update reports the completion of a study evaluating a dilemma-focused cognitive therapy for unipolar depression (major d…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety [NA]
A completed clinical trial evaluated pharmacogenetic-guided treatment versus standard-of-care treatment for depression and/or anxiety to det…
-
FDA approval · 2016-12-16FDA Approved: CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic chlordiazepoxide and amitriptyline hydrochloride combination from Mylan Pharmaceutic…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults [Phase 4]
Phase 4 trial assessing memantine for improving rehabilitation outcomes and preventing depression in older adults has completed with posted …
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: A Pychoeducational Intervention for Women With Diabetes [NA]
Completed clinical trial update reporting results of a psychoeducational intervention for women with diabetes addressing depression and anxi…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD [Phase 3]
A 6-month extension study to the B2061032 Phase 3 trial is evaluating the safety, tolerability, and efficacy of DVS SR in child and adolesce…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Adding Exercise to Antidepressant Medication Treatment for Depression [NA]
A completed clinical trial evaluating the addition of exercise to antidepressant therapy for depression; results posted in 2016.
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid Neuroimaging
An update on a clinical trial exploring the pathophysiology and potential treatment approaches for major depressive disorder using Brain Der…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial [Phase 3]
This update reports the completion of a Phase 3 non-inferiority trial comparing escitalopram, placebo, and transcranial direct current stimu…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: TRIAD - Treatment of Insomnia and Depression [Phase 2, Phase 3]
The TRIAD program evaluating treatment for insomnia and depression has completed Phase 2 and Phase 3 trials, with results posted in December…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Effectiveness of Telepsychiatry-based Culturally Sensitive Collaborative Treatment of Depressed Chinese Americans [NA]
A completed clinical trial evaluating the effectiveness of a telepsychiatry-based, culturally sensitive collaborative treatment for depressi…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans [NA]
This clinical trial evaluated the effectiveness and acceptability of MoodGYM for depressive symptoms in Chinese Americans with Major Depress…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Measurement-based Care for Depression in Resource-Poor Settings [Phase 4]
A Phase 4 clinical trial evaluating measurement-based care for depression in resource-poor settings has been completed.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Tai Chi Intervention for Chinese Americans With Depression [NA]
A completed clinical trial conducted by Massachusetts General Hospital evaluated Tai Chi as an intervention for depression in Chinese Americ…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: An HIV Intervention for Black Men at Risk - The Enhanced Sexual Health Intervention for Men (ES-HIM) [Phase 2]
Phase 2 results update for ES-HIM, a behavioral intervention to improve sexual health among Black men at risk for HIV.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Meditation to Reduce Caregiver Stress [NA]
A UCLA-sponsored clinical trial evaluating meditation to reduce caregiver stress has completed its study; it targeted caregivers of individu…
-
FDA approval · 2016-11-25FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for a venlafaxine hydrochloride generic product from BluePoint Laboratories under ANDA077653. Th…
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression [Phase 4]
A Phase 4 open trial evaluating duloxetine in outpatients with irritable bowel syndrome symptoms and comorbid major depression has completed…